The cluster is small in absolute dollar terms and lacks insider corroboration. Monitor next 13F for whether these additions were maintained or reversed, and watch for any insider buying that would strengthen the signal.
DCTH drugs
DCTH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $14.82entry
- T+1 · 12d ago −2.23%α +2.18% · $14.49
- T+5 · 6d ago +46.90%α +47.81% · $21.77
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three institutional asset managers increased their DCTH positions in Q3 2026, adding a net $2.7M in holdings. The buying is concentrated among smaller active managers, with Dimensional Fund Advisors making the largest addition. No insider buying corroborates the institutional accumulation.
Key Financial Metrics
Institutional Positions
Net institutional flow: $2.7M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Dimensional Fund Advisors | ADD | +49.7% | $5.0M | $2.4M |
| Alps Advisors | ADD | +30.3% | $729.0K | $288.0K |
| Farther Finance Advisors | ADD | +82.1% | $5.0K | $3.0K |
Key Facts
- 3 institutional buyers added a net $2.7M in DCTH during Q3 2026
- Dimensional Fund Advisors increased its stake by 49.7% (104.6K shares, +$2.4M)
- Alps Advisors added 30.3% (10.6K shares, +$288K)
- Farther Finance Advisors added 82.1% (133 shares, +$3K)
- No institutional sellers were identified in the cluster
- Insider-institutional confluence score is low (19/100), with no open-market insider buying
Financial Impact
Net institutional buying of $2.7M, representing approximately 0.55% of market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying to corroborate the institutional thesis
- Total buying of $2.7M is modest relative to $487M market cap
- All three buyers are asset managers, not activist or event-driven funds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-DCTH-2026-Q3 |
Track record
12 reports on DCTH
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +27.22% at T+60 after the Feb 26, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $21.38 settles Feb 10
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $20.27 settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Viewing Entry $14.82 settles Feb 2
- Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $14.86 settles Jan 26
- Oct 19, 202628d ago SC 13D/A Neutral 4/10 Entry $14.37 settles Jan 14
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $11.77 to $16.48 ▲ +40.08% +35.68% vs SPY
- May 14, 202626w ago 8-K Neutral 3/10 Entry $11.46 to $16.67 ▲ +45.46% +41.87% vs SPY
- May 7, 202627w ago 8-K Neutral 5/10 Entry $11.24 to $13.04 ▲ +16.01% +12.18% vs SPY
- Apr 2, 202632w ago DEFA14A Neutral 3/10 Entry $9.63 to $12.59 ▲ +30.74% +16.58% vs SPY
- Mar 2, 202637w ago Insider Cluster Bullish 6/10 Entry $8.93 to $10.83 ▲ +21.28% +11.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers